Drug Type Small molecule drug |
Synonyms ATPace |
Target |
Action agonists |
Mechanism Purinergic P2 receptor agonists |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H16N5O13P3 |
InChIKeyZKHQWZAMYRWXGA-KQYNXXCUSA-N |
CAS Registry56-65-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tachycardia | Phase 3 | - | - | |
Tachycardia | Phase 3 | - | - | |
Tachycardia | Phase 3 | - | - | |
Tachycardia | Phase 3 | - | - | |
Alzheimer Disease | Phase 2 | Spain | 01 Dec 2014 | |
Bradycardia | Phase 2 | United States | - | |
Bradycardia | Phase 2 | Canada | - | |
Bradycardia | Phase 2 | - | - | |
Bradycardia | Phase 2 | - | - | |
Bradycardia | Phase 2 | - | - |
Not Applicable | 58 | (Chronic Cough Participant) | qjnczrcood(waxfnretts) = zkhrtdtmcu auhkmriqwd (dhgtdcmwrz, 0.60) View more | - | 22 Aug 2024 | ||
(Healthy Control Participant) | qjnczrcood(waxfnretts) = wmicrwwazp auhkmriqwd (dhgtdcmwrz, 0.47) View more | ||||||
Not Applicable | - | 119 | Intravenous ATP infusion | lcmulfwksw(qoddnpajaw) = afohjbqhlw ptwrwwgvnb (wuceugwrty ) View more | - | 03 Sep 2019 | |
Additional intracoronary papaverine administration | lcmulfwksw(qoddnpajaw) = acmxbrpmhl ptwrwwgvnb (wuceugwrty ) View more | ||||||
Not Applicable | - | - | oATP | frgryyufch(tukuabhqxe) = pbgwfpgegu rqnxtjhrcp (wdtxsyvmro ) View more | Positive | 01 Jul 2019 | |
Control (sterile saline) | frgryyufch(tukuabhqxe) = tpvrhdiwrv rqnxtjhrcp (wdtxsyvmro ) View more |